English  |  正體中文  |  简体中文  |  2830311  
???header.visitor??? :  32534697    ???header.onlineuser??? :  1205
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"ryu mh"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 11-14 of 14  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2017-12 Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised, double-blind, placebo-controlled, phase 3 trial Kang, YK;Boku, N;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Chen, LT
國家衛生研究院 2017-10 Anti-angiogenic therapy in patients with advanced gastric and gastroesophageal junction cancer: A systematic review Chen, LT;Oh, DY;Ryu, MH;Yeh, KH;Yeo, W;Carlesi, R;Cheng, R;Kim, J;Orlando, M;Kang, YK
國家衛生研究院 2017-02 Nivolumab (ONO-4538/BMS-936558) as salvage treatment after second or later-line chemotherapy for advanced gastric or gastroesophageal junction cancer (AGC): A double-blinded, randomized, phase III trial Kang, YK;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yoshikawa, T;Oh, SC;Tamura, T;Lee, KW;Boku, N;Chen, LT
國家衛生研究院 2016-10 Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor Koo, DH;Ryu, MH;Kim, KM;Yang, HK;Sawaki, A;Hirota, S;Zheng, J;Zhang, B;Tzen, CY;Yeh, CN;Nishida, T;Shen, L;Chen, LT;Kang, YK

Showing items 11-14 of 14  (1 Page(s) Totally)
1 
View [10|25|50] records per page